Magnetic field-assisted gene delivery: achievements and therapeutic potential.
暂无分享,去创建一个
Jose I Schwerdt | Gerardo F Goya | M Pilar Calatayud | Claudia B Hereñú | Paula C Reggiani | Rodolfo G Goya | G. Goya | M. P. Calatayud | C. Hereñú | J. I. Schwerdt | R. Goya | P. Reggiani | P. Calatayud
[1] H. Küchenhoff,et al. Neoadjuvant gene delivery of feline granulocyte‐macrophage colony‐stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial , 2008, The journal of gene medicine.
[2] C. Pellegrino,et al. Efficient transfection of DNA or shRNA vectors into neurons using magnetofection , 2007, Nature Protocols.
[3] Kenneth A. Barbee,et al. Targeted drug delivery to magnetic implants for therapeutic applications , 2005 .
[4] M. Conese,et al. Magnetically guided lentiviral‐mediated transduction of airway epithelial cells , 2010, The journal of gene medicine.
[5] R. Crystal,et al. Gene therapy with adenovirus-mediated myocardial transfer of vascular endothelial growth factor 121 improves cardiac performance in a pacing model of congestive heart failure. , 2002, The Journal of thoracic and cardiovascular surgery.
[6] G. Breen,et al. Differential Activity by Polymorphic Variants of a Remote Enhancer that Supports Galanin Expression in the Hypothalamus and Amygdala: Implications for Obesity, Depression and Alcoholism , 2011, Neuropsychopharmacology.
[7] D. Stewart,et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment , 2006, Gene Therapy.
[8] E. Portiansky,et al. Restorative effect of intracerebroventricular insulin-like growth factor-I gene therapy on motor performance in aging rats , 2011, Neuroscience.
[9] O. Mykhaylyk,et al. Magnetofection: Using Magnetic Particles and Magnetic Force to Enhance and to Target Nucleic Acid Delivery , 2008 .
[10] B. Davidson,et al. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat , 1999, Gene Therapy.
[11] Hao Zeng,et al. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. , 2004, Journal of the American Chemical Society.
[12] A Gruntzig,et al. Transluminal dilatation of coronary-artery stenosis. , 1978, Lancet.
[13] Christian Bergemann,et al. Physiological aspects in magnetic drug-targeting , 1999 .
[14] Mansoor Amiji,et al. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields , 2010, Proceedings of the National Academy of Sciences.
[15] T. Daly,et al. Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[16] A. Sinclair,et al. Ex vivo magnetofection: A novel strategy for the study of gene function in mouse organogenesis , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.
[17] Armin D. Ebner,et al. Isolated swine heart ventricle perfusion model for implant assisted-magnetic drug targeting. , 2008, International journal of pharmaceutics.
[18] Robert J Levy,et al. Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells. , 2009, Molecular pharmaceutics.
[19] Stefan Thalhammer,et al. Boosting oncolytic adenovirus potency with magnetic nanoparticles and magnetic force. , 2010, Molecular pharmaceutics.
[20] K. Brand. Gene Therapy for Cancer , 2003 .
[21] Timothy O'Brien,et al. Gene-eluting stents: comparison of adenoviral and adeno- associated viral gene delivery to the blood vessel wall in vivo. , 2006, Human gene therapy.
[22] Fulvio Mavilio,et al. Gene therapy , 1993, Nature.
[23] A. Sinusas,et al. Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging. , 2010, Journal of molecular and cellular cardiology.
[24] K. Eric Drexler,et al. Engines of Creation: the Coming Era of Nanotechnology , 1986 .
[25] J. Rosenecker,et al. Insights into the mechanism of magnetofection using PEI‐based magnetofectins for gene transfer , 2004, The journal of gene medicine.
[26] J. Gallo,et al. Distribution of Small Magnetic Particles in Brain Tumor-bearing Rats , 2004, Journal of Neuro-Oncology.
[27] W. Rossoll,et al. METHODOLOGY Open Access Methodology , 2022 .
[28] K. Widder,et al. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats. , 1983, European journal of cancer & clinical oncology.
[29] Christian Plank,et al. Magnetically enhanced nucleic acid delivery. Ten years of magnetofection—Progress and prospects , 2011, Advanced Drug Delivery Reviews.
[30] J. Rosenecker,et al. Gene delivery to respiratory epithelial cells by magnetofection , 2004, The journal of gene medicine.
[31] J. Hartikainen,et al. Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia: Phase II Results of the Kuopio Angiogenesis Trial (KAT) , 2003, Circulation.
[32] J. Leiden,et al. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. , 1995, The Journal of clinical investigation.
[33] N. Nukina,et al. rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse. , 2006, Biochemical and biophysical research communications.
[34] D. Staudacher,et al. Cell and gene therapies in cardiovascular disease with special focus on the no option patient. , 2006, Current gene therapy.
[35] J. Marco,et al. Uniform and water stable magnetite nanoparticles with diameters around the monodomain–multidomain limit , 2008 .
[36] R. Costo,et al. Magnetic Nanoparticles for Power Absorption: optimizing size, shape and magnetic properties. , 2009, 0901.3891.
[37] S. Sell. Potential gene therapy strategies for cancer stem cells. , 2006, Current gene therapy.
[38] D. Geddes,et al. Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo , 2006, Gene Therapy.
[39] M. Bally,et al. Gene silencing in the development of personalized cancer treatment: the targets, the agents and the delivery systems. , 2006, Current gene therapy.
[40] O. Mykhaylyk,et al. Glial brain tumor targeting of magnetite nanoparticles in rats , 2001 .
[41] Mitsuhiro Hashimoto,et al. Directional gene-transfer into the brain by an adenoviral vector tagged with magnetic nanoparticles , 2011, Journal of Neuroscience Methods.
[42] Hao Zeng,et al. DNA-functionalized MFe2O4 (M = Fe, Co, or Mn) nanoparticles and their hybridization to DNA-functionalized surfaces. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[43] Y. Yoshioka,et al. Direct cell entry of gold/iron-oxide magnetic nanoparticles in adenovirus mediated gene delivery. , 2009, Biomaterials.
[44] C. Alexiou,et al. Locoregional cancer treatment with magnetic drug targeting. , 2000, Cancer research.
[45] J. Bloch,et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. , 2000, Science.
[46] M. Pickard,et al. Magnetic nanoparticle-mediated gene transfer to oligodendrocyte precursor cell transplant populations is enhanced by magnetofection strategies. , 2011, ACS nano.
[47] P Reichardt,et al. Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. , 1996, Cancer research.
[48] Craig Pratt,et al. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. , 2003, Journal of the American College of Cardiology.
[49] Armin D. Ebner,et al. Magnetizable implants and functionalized magnetic carriers: A novel approach for noninvasive yet targeted drug delivery , 2005 .
[50] C. Marquina,et al. Magnetic Hyperthermia With Fe$_{3}$O $_{4}$ Nanoparticles: The Influence of Particle Size on Energy Absorption , 2008, IEEE transactions on magnetics.
[51] B. Davidson,et al. Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy , 1997, Science.
[52] Armin D. Ebner,et al. Analysis of magnetic drug carrier particle capture by a magnetizable intravascular stent—2: Parametric study with multi-wire two-dimensional model , 2005 .
[53] J. Dobson,et al. Magnetic nanoparticles for gene and drug delivery , 2008, International journal of nanomedicine.
[54] J. Gallo,et al. Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres. , 1998, Journal of drug targeting.
[55] J. Glorioso,et al. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-β peptide in vivo , 2006, Gene Therapy.
[56] K. Jang,et al. N-hexanoyl chitosan-stabilized magnetic nanoparticles: enhancement of adenoviral-mediated gene expression both in vitro and in vivo. , 2008, Nanomedicine : nanotechnology, biology, and medicine.
[57] Y. Chernajovsky,et al. Cloning and expression of murine IFNβ and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis , 1998, Gene Therapy.
[58] E. Portiansky,et al. The ependymal route for insulin-like growth factor-1 gene therapy in the brain , 2009, Neuroscience.
[59] E. Portiansky,et al. Restorative effect of insulin-like growth factor-I gene therapy in the hypothalamus of senile rats with dopaminergic dysfunction , 2007, Gene Therapy.
[60] Tommy Olsson,et al. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy. , 2010, Biomaterials.
[61] Hirokazu Akiyama,et al. Genetically engineered angiogenic cell sheets using magnetic force-based gene delivery and tissue fabrication techniques. , 2010, Biomaterials.
[62] O. Mykhaylyk,et al. Non-viral VEGF165 gene therapy – magnetofection of acoustically active magnetic lipospheres (‘magnetobubbles’) increases tissue survival in an oversized skin flap model , 2008, Journal of cellular and molecular medicine.
[63] Carl K. Hoh,et al. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy , 1999 .
[64] J. A. Ritter,et al. Analysis of magnetic drug carrier particle capture by a magnetizable intravascular stent: 1. Parametric study with single wire correlation , 2004 .
[65] Y. Yoon,et al. Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents: An Alternative Strategy for Inhibition of Restenosis , 2004, Circulation.
[66] J Henke,et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo , 2002, Gene Therapy.
[67] Christian Plank,et al. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro , 2007, Nature Protocols.
[68] K. Widder,et al. Magnetic Microspheres: A Model System for Site Specific Drug Delivery in Vivo 1 , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[69] E. Portiansky,et al. Impact of very old age on hypothalamic dopaminergic neurons in the female rat: A morphometric study , 2003, The Journal of comparative neurology.
[70] R. Coffman,et al. Central Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.
[71] In-Kyu Park,et al. Hybrid superparamagnetic iron oxide nanoparticle-branched polyethylenimine magnetoplexes for gene transfection of vascular endothelial cells. , 2010, Biomaterials.
[72] C. Plank,et al. Magnetofection Potentiates Gene Delivery to Cultured Endothelial Cells , 2003, Journal of Vascular Research.
[73] E. Matijević,et al. Ferric hydrous oxide sols , 1978 .
[74] Gary Friedman,et al. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents , 2008, Proceedings of the National Academy of Sciences.
[75] Christophe Béclin,et al. High transfection efficiency of neural stem cells with magnetofection. , 2011, BioTechniques.
[76] T. Ogihara,et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[77] Steven G Potkin,et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease , 2005, Nature Medicine.
[78] S. Goodwin,et al. Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[79] D. Huhn,et al. Preclinical experiences with magnetic drug targeting: tolerance and efficacy. , 1996, Cancer research.
[80] H. Küchenhoff,et al. Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study. , 2007, Journal of veterinary medicine. A, Physiology, pathology, clinical medicine.
[81] M. Feldmann,et al. Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system. , 1998, Journal of immunology.
[82] M. Bellini,et al. Glial cell line-derived neurotrophic factor gene therapy ameliorates chronic hyperprolactinemia in senile rats , 2010, Neuroscience.
[83] R. Favaloro,et al. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. , 1968, The Annals of thoracic surgery.
[84] M. Ibarra,et al. Magnetic nanoparticles for local drug delivery using magnetic implants. , 2009, Methods in molecular biology.
[85] M. Pickard,et al. The transfection of multipotent neural precursor/stem cell transplant populations with magnetic nanoparticles. , 2011, Biomaterials.
[86] C Alexiou,et al. Clinical applications of magnetic drug targeting. , 2001, The Journal of surgical research.
[87] J. M. Vargas,et al. Tailoring the size in colloidal iron oxide magnetic nanoparticles , 2005 .
[88] Armin D. Ebner,et al. In vitro study of ferromagnetic stents for implant assisted-magnetic drug targeting , 2007 .
[89] Tomas Björklund,et al. Restoration of the striatal dopamine synthesis for Parkinson's disease: viral vector-mediated enzyme replacement strategy. , 2007, Current gene therapy.
[90] R. Neve,et al. Gene Therapy for Chronic Relapsing Experimental Allergic Encephalomyelitis Using Cells Expressing a Novel Soluble p75 Dimeric TNF Receptor1 , 2000, The Journal of Immunology.
[91] Minjian Kong,et al. Tumor-targeting magnetic lipoplex delivery of short hairpin RNA suppresses IGF-1R overexpression of lung adenocarcinoma A549 cells in vitro and in vivo. , 2011, Biochemical and biophysical research communications.
[92] Jon Dobson,et al. Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.